ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 08 Feb 2021
Last Applicant/ Owned by
Limin Economic Development
Zone, Harbin
CN
150025
Serial Number
88258818 filed on 11th Jan 2019
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
HTUP
Active chemical ingredients for use in the manufacture of anti-cancer drugs; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Heterocyclic compounds; Chemicals, namely, acetylene, calcium phosphate and dichloroethane; Phenothiazi Read More
Classification Information
Class [001]
Chemical Products
Active chemical ingredients for use in the manufacture of anti-cancer drugs; Active chemical ingredients for use in the manufacture of pharmaceuticals for treating gastrointestinal, cancer, infection, neurological, cardiovascular, musculoskeletal and immune system related diseases and disorders; Heterocyclic compounds; Chemicals, namely, acetylene, calcium phosphate and dichloroethane; Phenothiazine for use as a pharmaceutical intermediate; Reagents and substrates, namely, chemical compounds for use in patterning at nano scale or near nano scale
Mark Details
Serial Number
No 88258818
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 08th Feb 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| 08th Feb 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 26th May 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd May 2020 | EXTENSION 2 FILED |
| 22nd May 2020 | EXTENSION 2 GRANTED |
| 22nd May 2020 | TEAS EXTENSION RECEIVED |
| 19th Dec 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 17th Dec 2019 | TEAS EXTENSION RECEIVED |
| 17th Dec 2019 | EXTENSION 1 FILED |
| 17th Dec 2019 | EXTENSION 1 GRANTED |